Weekly Digest – April 2025 Weekly Digest – April 2025 17 Apr 2025: Blenrep (Belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple Myeloma UK MHRA approved Blenrep (Belantamab mafodotin) in combination therapies for relapsed/refractory multiple Myeloma, marking the […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id